4,476 research outputs found
Cancer diagnosis using deep learning: A bibliographic review
In this paper, we first describe the basics of the field of cancer diagnosis, which includes steps of cancer diagnosis followed by the typical classification methods used by doctors, providing a historical idea of cancer classification techniques to the readers. These methods include Asymmetry, Border, Color and Diameter (ABCD) method, seven-point detection method, Menzies method, and pattern analysis. They are used regularly by doctors for cancer diagnosis, although they are not considered very efficient for obtaining better performance. Moreover, considering all types of audience, the basic evaluation criteria are also discussed. The criteria include the receiver operating characteristic curve (ROC curve), Area under the ROC curve (AUC), F1 score, accuracy, specificity, sensitivity, precision, dice-coefficient, average accuracy, and Jaccard index. Previously used methods are considered inefficient, asking for better and smarter methods for cancer diagnosis. Artificial intelligence and cancer diagnosis are gaining attention as a way to define better diagnostic tools. In particular, deep neural networks can be successfully used for intelligent image analysis. The basic framework of how this machine learning works on medical imaging is provided in this study, i.e., pre-processing, image segmentation and post-processing. The second part of this manuscript describes the different deep learning techniques, such as convolutional neural networks (CNNs), generative adversarial models (GANs), deep autoencoders (DANs), restricted Boltzmann’s machine (RBM), stacked autoencoders (SAE), convolutional autoencoders (CAE), recurrent neural networks (RNNs), long short-term memory (LTSM), multi-scale convolutional neural network (M-CNN), multi-instance learning convolutional neural network (MIL-CNN). For each technique, we provide Python codes, to allow interested readers to experiment with the cited algorithms on their own diagnostic problems. The third part of this manuscript compiles the successfully applied deep learning models for different types of cancers. Considering the length of the manuscript, we restrict ourselves to the discussion of breast cancer, lung cancer, brain cancer, and skin cancer. The purpose of this bibliographic review is to provide researchers opting to work in implementing deep learning and artificial neural networks for cancer diagnosis a knowledge from scratch of the state-of-the-art achievements
A study of machine learning and deep learning models for solving medical imaging problems
Application of machine learning and deep learning methods on medical imaging aims to create systems that can help in the diagnosis of disease and the automation of analyzing medical images in order to facilitate treatment planning. Deep learning methods do well in image recognition, but medical images present unique challenges. The lack of large amounts of data, the image size, and the high class-imbalance in most datasets, makes training a machine learning model to recognize a particular pattern that is typically present only in case images a formidable task.
Experiments are conducted to classify breast cancer images as healthy or non-healthy, and to detect lesions in damaged brain MRI (Magnetic Resonance Imaging) scans. Random Forest, Logistic Regression and Support Vector Machine perform competitively in the classification experiments, but in general, deep neural networks beat all conventional methods. Gaussian Naïve Bayes (GNB) and the Lesion Identification with Neighborhood Data Analysis (LINDA) methods produce better lesion detection results than single path neural networks, but a multi-modal, multi-path deep neural network beats all other methods. The importance of pre-processing training data is also highlighted and demonstrated, especially for medical images, which require extensive preparation to improve classifier and detector performance. Only a more complex and deeper neural network combined with properly pre-processed data can produce the desired accuracy levels that can rival and maybe exceed those of human experts
Prospects for Theranostics in Neurosurgical Imaging: Empowering Confocal Laser Endomicroscopy Diagnostics via Deep Learning
Confocal laser endomicroscopy (CLE) is an advanced optical fluorescence
imaging technology that has the potential to increase intraoperative precision,
extend resection, and tailor surgery for malignant invasive brain tumors
because of its subcellular dimension resolution. Despite its promising
diagnostic potential, interpreting the gray tone fluorescence images can be
difficult for untrained users. In this review, we provide a detailed
description of bioinformatical analysis methodology of CLE images that begins
to assist the neurosurgeon and pathologist to rapidly connect on-the-fly
intraoperative imaging, pathology, and surgical observation into a
conclusionary system within the concept of theranostics. We present an overview
and discuss deep learning models for automatic detection of the diagnostic CLE
images and discuss various training regimes and ensemble modeling effect on the
power of deep learning predictive models. Two major approaches reviewed in this
paper include the models that can automatically classify CLE images into
diagnostic/nondiagnostic, glioma/nonglioma, tumor/injury/normal categories and
models that can localize histological features on the CLE images using weakly
supervised methods. We also briefly review advances in the deep learning
approaches used for CLE image analysis in other organs. Significant advances in
speed and precision of automated diagnostic frame selection would augment the
diagnostic potential of CLE, improve operative workflow and integration into
brain tumor surgery. Such technology and bioinformatics analytics lend
themselves to improved precision, personalization, and theranostics in brain
tumor treatment.Comment: See the final version published in Frontiers in Oncology here:
https://www.frontiersin.org/articles/10.3389/fonc.2018.00240/ful
3D Convolutional Neural Networks for Tumor Segmentation using Long-range 2D Context
We present an efficient deep learning approach for the challenging task of
tumor segmentation in multisequence MR images. In recent years, Convolutional
Neural Networks (CNN) have achieved state-of-the-art performances in a large
variety of recognition tasks in medical imaging. Because of the considerable
computational cost of CNNs, large volumes such as MRI are typically processed
by subvolumes, for instance slices (axial, coronal, sagittal) or small 3D
patches. In this paper we introduce a CNN-based model which efficiently
combines the advantages of the short-range 3D context and the long-range 2D
context. To overcome the limitations of specific choices of neural network
architectures, we also propose to merge outputs of several cascaded 2D-3D
models by a voxelwise voting strategy. Furthermore, we propose a network
architecture in which the different MR sequences are processed by separate
subnetworks in order to be more robust to the problem of missing MR sequences.
Finally, a simple and efficient algorithm for training large CNN models is
introduced. We evaluate our method on the public benchmark of the BRATS 2017
challenge on the task of multiclass segmentation of malignant brain tumors. Our
method achieves good performances and produces accurate segmentations with
median Dice scores of 0.918 (whole tumor), 0.883 (tumor core) and 0.854
(enhancing core). Our approach can be naturally applied to various tasks
involving segmentation of lesions or organs.Comment: Submitted to the journal Computerized Medical Imaging and Graphic
Recommended from our members
Machine Learning Decision Tree Models for Differentiation of Posterior Fossa Tumors Using Diffusion Histogram Analysis and Structural MRI Findings.
We applied machine learning algorithms for differentiation of posterior fossa tumors using apparent diffusion coefficient (ADC) histogram analysis and structural MRI findings. A total of 256 patients with intra-axial posterior fossa tumors were identified, of whom 248 were included in machine learning analysis, with at least 6 representative subjects per each tumor pathology. The ADC histograms of solid components of tumors, structural MRI findings, and patients' age were applied to construct decision models using Classification and Regression Tree analysis. We also compared different machine learning classification algorithms (i.e., naïve Bayes, random forest, neural networks, support vector machine with linear and polynomial kernel) for dichotomized differentiation of the 5 most common tumors in our cohort: metastasis (n = 65), hemangioblastoma (n = 44), pilocytic astrocytoma (n = 43), ependymoma (n = 27), and medulloblastoma (n = 26). The decision tree model could differentiate seven tumor histopathologies with terminal nodes yielding up to 90% accurate classification rates. In receiver operating characteristics (ROC) analysis, the decision tree model achieved greater area under the curve (AUC) for differentiation of pilocytic astrocytoma (p = 0.020); and atypical teratoid/rhabdoid tumor ATRT (p = 0.001) from other types of neoplasms compared to the official clinical report. However, neuroradiologists' interpretations had greater accuracy in differentiating metastases (p = 0.001). Among different machine learning algorithms, random forest models yielded the highest accuracy in dichotomized classification of the 5 most common tumor types; and in multiclass differentiation of all tumor types random forest yielded an averaged AUC of 0.961 in training datasets, and 0.873 in validation samples. Our study demonstrates the potential application of machine learning algorithms and decision trees for accurate differentiation of brain tumors based on pretreatment MRI. Using easy to apply and understandable imaging metrics, the proposed decision tree model can help radiologists with differentiation of posterior fossa tumors, especially in tumors with similar qualitative imaging characteristics. In particular, our decision tree model provided more accurate differentiation of pilocytic astrocytomas from ATRT than by neuroradiologists in clinical reads
Integrative analysis identifies candidate tumor microenvironment and intracellular signaling pathways that define tumor heterogeneity in NF1
Neurofibromatosis type 1 (NF1) is a monogenic syndrome that gives rise to numerous symptoms including cognitive impairment, skeletal abnormalities, and growth of benign nerve sheath tumors. Nearly all NF1 patients develop cutaneous neurofibromas (cNFs), which occur on the skin surface, whereas 40-60% of patients develop plexiform neurofibromas (pNFs), which are deeply embedded in the peripheral nerves. Patients with pNFs have a ~10% lifetime chance of these tumors becoming malignant peripheral nerve sheath tumors (MPNSTs). These tumors have a severe prognosis and few treatment options other than surgery. Given the lack of therapeutic options available to patients with these tumors, identification of druggable pathways or other key molecular features could aid ongoing therapeutic discovery studies. In this work, we used statistical and machine learning methods to analyze 77 NF1 tumors with genomic data to characterize key signaling pathways that distinguish these tumors and identify candidates for drug development. We identified subsets of latent gene expression variables that may be important in the identification and etiology of cNFs, pNFs, other neurofibromas, and MPNSTs. Furthermore, we characterized the association between these latent variables and genetic variants, immune deconvolution predictions, and protein activity predictions
Recommended from our members
DNA methylation-based classification of central nervous system tumours.
Accurate pathological diagnosis is crucial for optimal management of patients with cancer. For the approximately 100 known tumour types of the central nervous system, standardization of the diagnostic process has been shown to be particularly challenging-with substantial inter-observer variability in the histopathological diagnosis of many tumour types. Here we present a comprehensive approach for the DNA methylation-based classification of central nervous system tumours across all entities and age groups, and demonstrate its application in a routine diagnostic setting. We show that the availability of this method may have a substantial impact on diagnostic precision compared to standard methods, resulting in a change of diagnosis in up to 12% of prospective cases. For broader accessibility, we have designed a free online classifier tool, the use of which does not require any additional onsite data processing. Our results provide a blueprint for the generation of machine-learning-based tumour classifiers across other cancer entities, with the potential to fundamentally transform tumour pathology
A Genetic Algorithm Based Feature Selection for Classification of Brain MRI Scan Images Using Random Forest Classifier
A brain tumour is a mass of tissue that is formed by a gradual addition of anomalous cells and it is important to classify brain tumours from the magnetic resonance imaging (MRI) for treatment. Magnetic Resonance Imaging is a useful imaging technique that is widely used by physicians to investigate different pathologies. After a long clinical research, it is proved to be harmless. Improvement in computing power has introduced Computer Aided Diagnosis (CAD) which can efficiently work in an automated environment. Diagnosis or classification accuracy of such a CAD system is associated with the selection of features. This paper proposes an enhanced brain MRI image classifier targeting two main objectives, the first is to achieve maximum classification accuracy and second is to minimize the number of features for classification. Feature selection is performed using Genetic Algorithm (GA) while classifiers used are Random forest Classifier
- …